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Summary
 
Recent data indicate that several members of the Tec family of protein tyrosine kinases func-
tion in antigen receptor signal transduction. Txk, a Tec family protein tyrosine kinase, is ex-
pressed in both immature and mature T cells and in mast cells. By overexpressing Txk in T
cells throughout development, we found that Txk specifically augments the phospholipase C
(PLC)-
 
g
 
1–mediated calcium signal transduction pathway upon T cell antigen receptor (TCR)
engagement. Although Txk is structurally different from inducible T cell kinase (Itk), another
Tec family member expressed in T cells, expression of the Txk transgene could partially rescue
 
defects in positive selection and signaling in 
 
itk
 
2
 
/
 
2
 
 mice. Conversely, in the 
 
itk
 
1
 
/
 
1
 
 (wild-type)
background, overexpression of Txk inhibited positive selection of TCR transgenic thymo-
cytes, presumably due to induction of cell death. These results identify a role for Txk in TCR
signal transduction, T cell development, and selection and suggest that the Tec family kinases
Itk and Txk perform analogous functions.
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T
 
he tyrosine kinase Txk (also known as Rlk [1–3]) is a
member of a new family of Src superfamily nonrecep-
tor tyrosine kinases, the Tec family. Tec family members
share Src homology 3 (SH3),
 
1
 
 SH2, and tyrosine kinase
catalytic domains with each other and with Src family ki-
nases. Unlike Src family kinases such as Lck and Fyn, Tec
family members do not contain a negative regulatory ty-
rosine in their catalytic domains nor do they contain a myris-
tylation site in their NH
 
2
 
-terminal domains. In the mouse,
Tec family members include Bruton’s tyrosine kinase (Btk
[4]), inducible T cell kinase (Itk [5–7]), Tec (8), Txk (1, 2),
and Bmx (9). All of the family members with the exception
of Bmx contain a Tec homology domain, which includes a
proline-rich SH3-binding domain, in their NH
 
2
 
-terminal
regions. All Tec family members except Txk contain a
pleckstrin homology (PH) domain in their NH
 
2
 
-terminal
regions. In general, Src superfamily kinases acquire an “in-
active” conformation when their SH2 domains interact
with the negative regulatory phosphotyrosine in their cata-
lytic domains. The Tec family kinases do not possess a neg-
ative regulatory phosphotyrosine but appear to use another
negative intramolecular regulatory interaction between their
SH3 and proline-rich SH3-binding domains (10).
Tec family members have restricted expression almost
exclusively within hematopoietic cells. Btk is expressed in
B and myeloid cell lineages (4, 11, 12), Itk in T, myeloid,
and mast cell lineages (5–7), Tec in T, B, and myeloid cell
lineages (8, 13, 14), Txk in T and mast cell lineages (1, 2),
and Bmx in the granulo-monocytic lineage (9). The func-
tions of some of these family members in the development
of particular hematopoietic lineages have been investigated
in human disease and in mouse model systems. Naturally
occurring mutations in 
 
btk
 
 in humans result in X-linked
agammaglobulinemia (for reviews, see references 15 and
16), revealing an absolute requirement for Btk function in
B cell development in humans. In mice, mutation of 
 
btk
 
 re-
sults in X-linked immunodeficiency (17, 18), and 
 
btk
 
knockout mice show a similar phenotype (19, 20), indicat-
ing that Btk is also important for B cell development and
function in mice. T cell development and function have
been analyzed in 
 
itk 
 
knockout mice (21–23). These mice
show defects in T cell development and thymocyte selec-
tion, which are most evident when they are also transgenic
for defined TCR genes (21). T cell proliferation and IL-2
production are also impaired in 
 
itk
 
 knockout mice in re-
sponse to TCR cross-linking (21, 22).
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; Btk, Bruton’s tyrosine ki-
nase; DP, CD4
 
1
 
CD8
 
1
 
 double positive; DN, CD4
 
2
 
CD8
 
2
 
 double nega-
tive; Itk, inducible T cell kinase; MAP, mitogen-activated protein; PH,
pleckstrin homology; PLC, phospholipase C; SH3, Src homology 3; SP,
CD4
 
1
 
CD8
 
2
 
 or CD4
 
2
 
CD8
 
1
 
 single positive. 
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Effects of Txk Overexpression on T Cell Activation
 
Txk is expressed in both immature and mature T cells (1,
2); however, its role in T cell signaling and development
has remained less well characterized. In a recent report,
mice lacking Txk were found to exhibit only a mild im-
pairment in TCR signaling (24). However, in the absence
of both Txk and Itk, the TCR signaling defects in 
 
itk
 
2
 
/
 
2
 
mice were exacerbated, suggesting that these proteins may
perform similar functions (24). Consistent with this idea,
current data indicate that both Itk and Txk as well as Btk
function specifically in the signaling pathway leading to
phospholipase C (PLC)-
 
g
 
 activation and calcium mobiliza-
tion (24–27).
To study Txk function, we generated transgenic mice
that overexpress Txk throughout T cell development. Al-
though T cell maturation appeared grossly unaffected, thy-
mocytes and peripheral T cells from 
 
txk
 
 transgenic mice
were hyperresponsive to TCR stimulation as assessed by
increased PLC-
 
g
 
1 phosphorylation and enhanced calcium
flux. Txk overexpression also resulted in enhanced IL-2
production after TCR engagement. Txk overexpression
inhibited positive selection in TCR transgenic mice, but
partially rescued the defect in positive selection in TCR
transgenic, 
 
itk
 
2
 
/
 
2
 
 mice. Since overexpression of Txk aug-
ments the TCR signaling response, the inhibition of posi-
tive selection in 
 
itk
 
1
 
/
 
1 
 
txk
 
 transgenic mice may be due to
the induction of programmed cell death in developing thy-
mocytes. Collectively, these results identify a role for Txk
in TCR signal transduction, T cell development, and thy-
mocyte selection, and provide evidence that Txk and Itk
perform analogous functions in T cells.
 
Materials and Methods
 
Mice.
 
For construction of the Txk transgenic vector, most of
the 3
 
9
 
 untranslated 
 
txk
 
 cDNA sequence was first eliminated by
digestion of the Bluescript SK plasmid containing the 
 
txk
 
 cDNA
(1) with BspM1 and XhoI and resealing of the plasmid incorpo-
rating an Sal1 linker to create a Sal1 site at the 3
 
9
 
 end of the 
 
txk
 
cDNA. Then the EcoR1-Sal1 
 
txk
 
 cDNA fragment was cloned
into a plasmid containing the CD2 promoter and enhancer (28)
and sequences from TCR-
 
z
 
 genomic DNA (29). The CD2/Txk/
TCR-
 
z
 
 sequences were separated from vector sequences by di-
gestion with Not1 and were isolated for pronuclear injection as
described previously (29). Txk transgenic mice were backcrossed
to C57BL/6 (B6) mice for 
 
.
 
10 generations. TCR transgenic
mice used in these studies included H-Y and AND TCR trans-
genic mice. H-Y mice express an MHC class I–restricted TCR
for the male antigen H-Y (30), and AND mice express an MHC
class II–restricted TCR specific for pigeon cytochrome C (31).
All TCR transgenic mice were in the H-2D
 
b
 
 background. 
 
itk
 
knockout mice were kindly provided by D. Littman (New York
University Medical Center, New York, NY).
 
Cell Culture.
 
Thymocytes were cultured when necessary in
RPMI complete medium as described previously (1). The resting
period for thymocytes (see Fig. 4) was 5 h at 37
 
8
 
C, 5% CO
 
2
 
.
 
Antibodies.
 
Polyclonal antiserum against Txk peptide 1
(CKPLPPLPQEPPDER), found near the NH
 
2
 
 terminus of Txk,
conjugated to KLH was raised in rabbits by Covance, Inc. Pep-
tide synthesis was performed by Biosynthesis, Inc. Anti-CD3
(145-2C11) and anti-CD28 (37.51) were prepared in our labora-
 
tory by protein G column purification (Sigma Chemical Co.).
Polyclonal anti-Lck serum and anti–ZAP-70 ascites were pro-
vided by L. Samelson (National Institutes of Health). T3.70-
FITC was prepared in our laboratory. Commercial antibodies
used include anti-CD3–FITC (PharMingen), anti-CD4–PE (Phar-
Mingen), anti-CD8a–Quantum red (Sigma Chemical Co.), anti-
V
 
a
 
11–FITC (PharMingen), H57-597–biotin (PharMingen), poly-
clonal anti–bovine PLC-
 
g
 
1 (Upstate Biotechnology), mixed
monoclonal anti–bovine PLC-
 
g
 
1 (Upstate Biotechnology), and
antiphosphotyrosine (4G10; Upstate Biotechnology).
 
Metabolic Labeling and Immunoprecipitation.
 
10
 
8
 
 thymocytes were
incubated for 30 min at 37
 
8
 
C in 5 ml complete medium contain-
ing 5 mCi TRAN
 
35
 
SLABEL (ICN Biomedicals). For immuno-
precipitation, cell lysates were prepared by incubating cells in
NP-40 lysis buffer (50 mM Tris, pH 7.5, 150 mM NaCl, 10 mM
Hepes, 1 mM EDTA, 1 mM Na
 
3
 
VO
 
4
 
, 1% NP-40, and 1
 
3
 
Complete™
 
 
 
protease inhibitor cocktail; Roche) for 30 min on ice.
Lysates were cleared by microcentrifugation for 15 min at 12,000 
 
g
 
.
After incubation of lysates with appropriate antibodies, com-
plexes were collected with protein A–Sepharose (Sigma Chemi-
cal Co.) and washed three times with NP-40 wash buffer (same as
NP-40 lysis buffer except with 0.2% NP-40). Samples were
boiled in reducing sample buffer (0.175 M Tris, pH 6.8, 30%
glycerol, 3% SDS, 15% 
 
b
 
-mercaptoethanol, 0.1% bromophenol
blue) and subjected to PAGE. 10% polyacrylamide gels were used
in all cases except for immunoprecipitation with the ZAP-70 an-
tibody, in which case 12% gels were used. In the case of meta-
bolic labeling, gels were treated with DMSO and 20% 2,5-diphe-
nyloxazole (PPO) in DMSO, dried, and exposed to BioMax MR
film (Eastman Kodak Co.) and a BioMax TranScreen LE intensi-
fying screen. In cases of Western blotting, gels were transferred
by standard methods (32). For in vitro TCR cross-linking (see
Fig. 4), 10
 
8
 
 thymocytes were resuspended in RPMI 1640 at 10
 
7
 
cells/ml. 100 
 
m
 
g of biotinylated H57-597 and 100 
 
m
 
g of biotiny-
lated GK1.5 (both prepared in our laboratory) were added for 10
min on ice. After centrifugation, the cells were resuspended in
RPMI 1640 containing 20 
 
m
 
g/ml streptavidin (Life Technolo-
gies) for various times at 37
 
8
 
C. Extracts were then prepared in
Triton X-100 lysis buffer (same as NP-40 lysis buffer except with
1% Triton X-100 instead of 1% NP-40) as described above.
 
In Vitro Kinase Assay.
 
After immunoprecipitation with anti-
Txk antiserum or anti-Txk antiserum with Txk peptide 1 and wash-
ing with NP-40 wash buffer minus EDTA, complexes were incu-
bated with kinase buffer (20 mM Hepes, pH 7.5, 100 mM NaCl,
5 mM MnCl
 
2
 
, 5 mM MgCl
 
2
 
, 2 
 
m
 
M NaATP, 10 
 
m
 
Ci [
 
g
 
-
 
32
 
P]ATP,
and 10 
 
m
 
g enolase) for 15 min at room temperature. Complexes
were then boiled in reducing sample buffer and subjected to elec-
trophoresis on 10% polyacrylamide gels. The gels were then fixed,
Coomassie blue stained (32), and exposed to x-ray film (X-OMAT
AR; Eastman Kodak Co.).
 
Cytometry and Measurements of Calcium Flux.
 
Standard flow cy-
tometry was performed as described previously (33) using a Bec-
ton Dickinson FACScan™ and CELLQuest™ software. For cal-
cium flux studies, cells were washed and resuspended in HBSS/
FBS (HBSS with calcium and magnesium, 10 mM Hepes, and 1%
FBS). The calcium probe indo-1 and the detergent Pluronic
(Molecular Probes) were added at final concentrations of 10 
 
m
 
M
and 300 
 
m
 
g/
 
m
 
l, respectively. After washing, the cells were also
stained with anti-CD8
 
a
 
–FITC (PharMingen) and anti-CD4–PE
(PharMingen). Cells were analyzed on a FACS Vantage™ (Bec-
ton Dickinson) equipped with an argon laser tuned to 488 nm and
a krypton laser tuned to 360 nm. Indo-1 fluorescence was ana-
lyzed at 390/20 and 530/20 for bound and free probe, respec- 
1429
 
Sommers et al.
tively. The signals for bound and unbound indo-1 were collected
in linear mode. The FACS Vantage™ was equipped with two
modifications necessary for reproducible measurement of TCR-
induced calcium flux: a Time Zero injection module (Cytek) and
ratio offset, so that the gain of the fluorescence ratio could be in-
creased while keeping the baseline signal in the lower channels.
For each stimulation, an aliquot of cells was warmed at 37
 
8
 
C for
3 min before stimulation with TCR cross-linking antibody. Data
were collected for 30 s, at which time varying amounts of bio-
tinylated H57-597 (0.2–10 
 
m
 
g; PharMingen) were added in a to-
tal volume of 50 
 
m
 
l. At 60 s, 20 
 
m
 
g of streptavidin (Life Technol-
ogies), also in a total volume of 50 
 
m
 
l, was injected. Cells were
collected at a rate of 1,000–2,000 cells/s.
The kinetic data shown in Figs. 3 and 8 were generated using
the software programs WinList (Verity Software House, Inc.) and
Canvas (Deneba Software). The percentage of cells that responded
by an increase in intracellular calcium after stimulation with TCR
cross-linking antibody was determined using Multitime Software
for Analysis of Kinetic Flow Cytometry Data (Phoenix Flow Sys-
tems). A threshold of fluorescence ratio was determined in the
window of time before antibody addition. This threshold was
then applied to the time window after the addition of antibody
and streptavidin. The maximum number of cells above the
threshold averaged over a 6-s time interval was expressed as a
percentage of all of the cells in the same interval. From this
number, we subtracted the percentage of cells above threshold in
the resting time window to obtain the percentage of cells re-
sponding.
 
Cytokine ELISA Measurements.
 
CD4
 
1
 
 cells were isolated from
total LN cells using positive selection magnetic cell sorting
(MACS; Miltenyi Biotec) according to the manufacturer’s rec-
ommendations. CD4
 
1
 
 cell populations were 
 
.
 
95% pure as mea-
sured by standard flow cytometry. Measurements for levels of IL-2,
IL-4, and IFN-
 
g
 
 were performed by ELISA using the reagents
and protocol from PharMingen.
 
Results
 
Generation of txk Transgenic Mice.
 
To examine the role of
Txk in T cell development and TCR signal transduction,
we overexpressed Txk in transgenic mice. Transgene expres-
sion was driven by the human CD2 promoter/enhancer
(diagrammed in Fig. 1 a). The CD2 promoter was chosen
to drive Txk expression because it directs expression early
and throughout T cell development, i.e., in CD4
 
2
 
CD8
 
2
 
(double negative [DN]), CD4
 
1
 
CD8
 
1
 
 (double positive [DP]),
and CD4
 
1
 
CD8
 
2
 
 and CD4
 
2
 
CD8
 
1
 
 (single positive [SP])
thymocytes and in mature peripheral T cells (29; and Love,
P.E., unpublished observations), approximating the expres-
sion pattern of endogenous 
 
txk
 
 (1). Five founder lines were
established, and two founder lines showing the highest lev-
els of expression were analyzed. Fig. 1 shows Txk protein
overexpression in the founder line showing highest expres-
sion. Extracts from hemizygous and homozygous transgenic
thymocytes were immunoprecipitated with anti-Txk anti-
body after metabolic labeling (Fig. 1 b). In vitro immune
complex kinase assays were also performed using anti-Txk
Figure 1. Txk overexpression in transgenic
mice. (a) Transgenic construct for expressing Txk.
txk cDNA expression is driven by the human CD2
promoter and enhancer. Sequences from TCR-z
including intronic sequences were included to en-
hance message stability. (b) Metabolic labeling and
immunoprecipitation. Thymocytes from txk ho-
mozygous (txk tg/tg), txk hemizygous (txk tg), or
nontransgenic (wt) mice were subjected to meta-
bolic labeling using [35S]methionine and cysteine
before immunoprecipitation (IP) with anti-Txk or
anti-Lck polyclonal antiserum. Anti-Lck was used
to show equivalent loading. In lane 2, an excess of
the peptide used for immunization in preparing the
anti-Txk antiserum (p1) was included in the immu-
noprecipitation. Molecular mass markers (in kD)
are shown at the right. (c) In vitro kinase assay. In
lanes 1–4, extracts from thymocytes from wild-type
and txk hemizygous transgenic mice were immu-
noprecipitated with anti-Txk antiserum followed
by incubation with [32P]ATP and the substrate
enolase to assess kinase activity. Increased levels of
phosphorylated enolase are seen in the Txk trans-
genic thymocytes. This phosphorylation is blocked
by peptide 1 (p1, used for immunization in prepar-
ing the Txk antiserum) but not by another peptide
from Txk (p2). Extracts from LNs (ln) were also
analyzed. The identity of the high molecular mass
phosphorylated peptide (z116 kD) is unknown.1430 Effects of Txk Overexpression on T Cell Activation
antiserum to show the functionality of Txk in Txk trans-
genic mice. As shown in Fig. 1 c, the tyrosine kinase sub-
strate enolase was phosphorylated to a greater extent in ex-
tracts immunoprecipitated from txk transgenic thymocytes
compared with extracts from wild-type thymocytes. Greater
enolase phosphorylation was also seen for txk transgenic
LNs, as was expected from the expression pattern of the
CD2 promoter (28). Data averaged from several experi-
ments show that Txk protein overexpression was z10-fold
in txk homozygous transgenic mice. Increases in in vitro
kinase activity were also z10-fold in txk homozygous
transgenic mice.
Phenotype of txk Transgenic Mice. txk transgenic mice ex-
hibited normal development and fertility. T cell maturation
appeared unaffected as assessed by normal numbers of thy-
mocytes and T lymphocytes. In addition, percentages of thy-
mocyte subsets in txk transgenic mice (DN, DP, and SP
thymocytes) were normal, as were the ratios of CD41 to
CD81 cells in thymus and in LNs as determined from sev-
eral experiments (Fig. 2, and data not shown). Staining for
CD3 (Fig. 2) and the following markers (data not shown)
showed similar profiles for txk transgenic and nontransgenic
thymocytes (TCR-a/b, TCR-g/d, CD5, CD69, and CD24)
and lymphocytes (TCR-a/b, TCR-g/d, CD5, CD44,
and CD62L).
Augmentation of TCR-mediated Signaling in txk Transgenic
Mice. Because the Tec family kinases Itk and Btk have
been shown to regulate calcium flux in T and B cells, re-
spectively (26, 27), we analyzed calcium mobilization in re-
sponse to TCR cross-linking in txk transgenic thymocytes
and lymphocytes. Cells were preloaded with the calcium
dye indo-1, stained for CD4 and CD8, and then stimulated
with biotinylated anti–TCR-b antibody. At low concen-
trations of anti–TCR-b (1.0 mg/ml), the calcium response
was enhanced in txk transgenic DP thymocytes relative to
nontransgenic DP thymocytes as assessed by: (a) the per-
centage of cells responding (18.6 vs. 3.2%, respectively); (b)
the accelerated kinetics of the early calcium response; and
(c) the increased amplitude of the kinetic response (Fig. 3 a).
However, with higher concentrations of anti–TCR-b (10
mg/ml), the calcium response was equivalent in txk trans-
genic and nontransgenic thymocytes (data not shown). In
addition, the kinetics of the delayed calcium response were
similar in txk transgenic and nontransgenic mice (Fig. 3).
SP thymocytes and LN T cells from txk transgenic mice
exhibited similarly enhanced responses compared with
equivalent populations of nontransgenic cells when stimu-
lated with submaximal concentrations of antibody (Fig. 3).
Again, in txk transgenic mice the percentage of CD4 SP
cells responding was increased (75.3 vs. 37.6% cells respond-
ing for CD41 thymocytes, and 41.0 vs. 33.2% cells respond-
ing for CD41 lymphocytes), as were the kinetics and am-
plitude of the early calcium response (Fig. 3).
One outcome of an enhanced TCR-mediated calcium re-
sponse should be increased IL-2 production. We measured
cytokine production in CD41 LN cells from txk transgenic
mice after stimulation by plate-bound anti-CD3 or anti-
CD3 plus anti-CD28 (Table I). CD41 LN cells from txk
transgenic mice produced significantly more IL-2 than non-
transgenic CD41 T cells. Moreover, the effect of Txk over-
expression was dose dependent, since lymphocytes from txk
homozygous transgenic mice produced more IL-2 than lym-
phocytes from txk hemizygous transgenic mice. However,
no enhancement in proliferation was observed either in lym-
phocytes or thymocytes from txk transgenic mice in response
to TCR cross-linking using similar conditions to those used
for analysis of cytokine production (data not shown).
It has been previously reported that txk is preferentially
expressed in Th1 versus Th2 T cell clones (2). To investi-
gate whether Txk overexpression would direct CD41 lym-
phocytes down either a Th1 or Th2 developmental path-
way, we also measured levels of IL-4 and IFN-g in response
to TCR cross-linking. Table I shows that both IL-4 and
IFN-g secretion were increased in txk transgenic CD41 LN
cells, indicating an overall increase in cytokine production in
txk transgenic mice but no bias toward either the Th1- or
Th2-specific cytokine profile under these conditions.
Txk Selectively Enhances the Calcium Signaling Pathway.
To further investigate where in the TCR-mediated signal
transduction pathway Txk exerts its effect, we next exam-
ined phosphorylation levels and activities of several signal
transduction molecules known to be activated upon TCR
Figure 2. Phenotype of txk trans-
genic mice. (a) Thymocytes from
txk transgenic (txk tg) and nontrans-
genic (non-tg) mice were stained
with anti-CD4, anti-CD8, and anti-
CD3 and analyzed by flow cytome-
try. CD4 vs. CD8 profiles are shown
with percentages of thymocytes in-
dicated within quadrants of the dot
plots. Histograms of anti-CD3 stain-
ing are also shown. (b) LN cells
from txk transgenic and nontrans-
genic mice were stained with anti-
CD4, anti-CD8, and anti-CD3 and
analyzed by flow cytometry as de-
scribed in a.1431 Sommers et al.
engagement. Early events after engagement of the TCR
are phosphorylation of the z chain and CD3 subunits of the
TCR by Lck, and recruitment of ZAP-70 to the TCR
complex. Recruitment of adapter molecules to the TCR
complex then results in activation of two more distal path-
ways of signal transduction. The first pathway involves
PLC-g1–dependent phosphoinositol lipid metabolism and
leads to the release of calcium from intracellular stores and
the activation of protein kinase C. Another major signal
transduction pathway involves activation of Ras and the
mitogen-activated protein (MAP) kinases (for a review, see
reference 34). Tyrosine phosphorylation levels of early ef-
fectors of TCR signal transduction (TCR-z, ZAP-70, Lck)
did not vary between txk transgenic and B6 control thy-
mocytes either before or after TCR engagement (Fig. 4,
and data not shown). Similarly, tyrosine phosphorylation
(Vav) or kinase activity (Erk-2) of signal transduction mol-
ecules in the MAP kinase pathway was identical in txk
transgenic and nontransgenic thymocytes (data not shown).
Notably, tyrosine phosphorylation of PLC-g1 was repro-
ducibly greater in ex vivo thymocytes from txk transgenic
mice than from nontransgenic thymocytes (Fig. 4; these
results are representative of seven separate experiments).
Since ex vivo thymocytes are known to be activated to
Table I. Increased Cytokine Production by Txk Transgenic
CD41 Lymphocytes
Cell type Treatment IL-2 IL-4 IFN-g
pg/ml pg/ml pg/ml
wt Control ND ND ND
txk tg Control ND ND ND
txk tg/tg Control ND ND ND
wt Anti-CD3 ND 8 1,134
txk tg Anti-CD3 12 52 7,193
txk tg/tg Anti-CD3 56 65 8,245
wt Anti-CD3 plus anti-CD28 24 34 19,258
txk tg Anti-CD3 plus anti-CD28 2,994 120 43,780
txk tg/tg Anti-CD3 plus anti-CD28 6,064 146 26,435
IL-2, IL-4, and IFN-g production were determined by ELISA from
CD41 lymphocytes from wild-type (wt), txk homozygous transgenic
(tg/tg), and txk hemizygous transgenic (tg) mice. Lymphocytes were
plated under control conditions or with plate-bound anti-CD3 or plate-
bound anti-CD3 and anti-CD28. Supernatants were analyzed after 24
(IL-4) or 48 (IL-2, IFN-g) h. The results are representative of three ex-
periments. ND, none detected.
Figure 3. The calcium response is en-
hanced in Txk transgenic thymocytes and
lymphocytes. (a) Wild-type B6 and Txk
transgenic thymocytes were preloaded with
the calcium dye indo-1 and then stimulated
by the addition of 1.0 mg of biotin-H57
(anti–TCR-b) antibody at 30 s and 20 mg of
streptavidin (cross-linking agent) at 60 s.
Fluorescence indicating bound and unbound
indo-1 was monitored over time (5 min),
and kinetic data were analyzed using Win-
List software. The cells were also stained
with anti-CD4 and anti-CD8, so that cal-
cium flux data could be obtained on gated
thymocyte subpopulations. (b) B6 and Txk
transgenic LN cells were treated and ana-
lyzed as described in a, except that 0.5 mg of
biotin-H57 was used. Results are representa-
tive of at least four separate experiments.1432 Effects of Txk Overexpression on T Cell Activation
some extent due to contact with thymic epithelial cells (35),
we also determined the tyrosine phosphorylation levels of
PLC-g1 in thymocytes that had been “rested” by incuba-
tion at 378C for 5 h in the absence of thymic epithelial
cells. In rested thymocytes, the level of PLC-g1 phosphor-
ylation was low and appeared equivalent in control and
txk transgenic thymocytes (Fig. 4). In addition, PLC-g1
phosphorylation was equivalent in thymocytes from txk
transgenic and nontransgenic mice that had been acti-
vated for 5 min with anti-TCR plus anti-CD4 antibodies
(Fig. 4). However, a time course analysis revealed that at early
time points after TCR engagement (0.5–1 min), PLC-g1
phosphorylation was greater in thymocytes from txk trans-
genic mice (Fig. 5). This effect was transgene dose dependent,
as the level of PLC-g1 phosphorylation was greater in ho-
mozygous transgenic than in hemizygous transgenic mice
(Fig. 5). Interestingly, at later time points (.1 min) the ex-
tent of PLC-g1 phosphorylation was equivalent in nontrans-
genic, hemizygous transgenic, and homozygous transgenic
mice (Fig. 5). The amount of inositol trisphosphate gener-
ated in thymocytes from nontransgenic, hemizygous trans-
genic, and homozygous transgenic mice was also equivalent
at 1, 2, and 5 min after TCR cross-linking (data not shown);
however, inositol trisphosphate levels at earlier (,1 min)
time points were not measured. Together these results reveal
that within a certain window, txk transgenic T cells appear
hyperactivated as measured by enhanced calcium flux kinet-
ics and by the level of PLC-g1 tyrosine phosphorylation.
Effect of Txk Overexpression on Thymocyte Selection. A sen-
sitive measure of the effects of T cell activation on thymo-
cyte development can be obtained using TCR transgenic
mice to examine thymocyte positive and negative selection.
To determine if positive selection was affected in txk trans-
genic mice, we used the H-Y transgenic TCR (30) and the
AND transgenic TCR (31). The H-Y transgenic TCR is
class I restricted and H-2Db specific. The antigen for the H-Y
transgenic TCR is from the male-specific protein H-Y, and
T cells expressing the transgenic TCR undergo positive se-
lection in female mice and negative selection in male mice.
In female H-Y transgenic mice, both the percentage and
total number of CD8 SP thymocytes expressing high levels
of the transgenic TCR (as detected by staining with the H-Y
TCR clonotype-specific antibody T3.70) were reduced in
txk transgenic mice compared with non-txk transgenic lit-
termates (Fig. 6). This effect was observed consistently within
multiple individual experiments comparing age-matched
mice (Fig. 6 b). Moreover, in all experiments, the percent-
age and total number of transgenic TCRhi (T3.70hi) DP
thymocytes (the direct precursors of T3.70high CD8 SP thy-
mocytes) were increased in txk transgenic mice (Fig. 6).
Again, the effect of the txk transgene was dose dependent,
since the reduction in T3.70hi CD8 SP thymocytes was
greater in homozygous txk transgenic mice than in hemizy-
gous txk transgenic mice (Table II). Thus, overexpression
of Txk inhibited thymocyte positive selection in H-Y fe-
males, resulting in a specific reduction in the number of
T3.70hi CD8 SP thymocytes.
Similar results were obtained in mice expressing the class
II–restricted transgenic TCR, AND. The number of trans-
genic TCRhi CD4 SP thymocytes (as detected by staining
Figure 4. Enhanced phosphorylation of PLC-g1 in txk transgenic thy-
mocytes. Extracts from wild-type B6 (wt thy) or txk transgenic thy-
mocytes (txk tg thy) were made immediately after removal from the ani-
mal (ex vivo), after a period of incubation of 5 h at 378C (rested), or after
treatment with biotinylated anti-TCR (H57) and anti-CD4 (GK1.5) and
cross-linking with streptavidin for 5 min. The control lane represents im-
munoprecipitation of lysis buffer instead of cell extract. Immunoprecipita-
tions with anti–PLC-g1 (top two rows) or anti–ZAP-70 (bottom two
rows) were performed. In the first row, the PLC-g1 immunoprecipita-
tion (IP) was followed with an antiphosphotyrosine (4G10) blot. The blot
was stripped and reprobed with an additional PLC-g1 antibody (second
row). In the third and fourth rows, the ZAP-70 immunoprecipitation was
followed by antiphosphotyrosine (p-tyr) blotting. The region of the blot
showing ZAP-70 (70 kD) is shown in the third row, and the region
showing TCR-z (p21 and p23 forms) is shown in the last row.
Figure 5. Time course of PLC-g1 phosphorylation after TCR cross-
linking. Thymocytes from nontransgenic (WT), txk hemizygous trans-
genic (txk tg), and txk homozygous transgenic (txk tg/tg) mice were iso-
lated, enumerated, and rested at 378C for 5 h. Rested thymocytes (108)
were then incubated with biotinylated anti-TCR (H57) and anti-CD4
(GK1.5) on ice and cross-linked with streptavidin at 378C for the times
indicated. Cell lysates were immunoprecipitated (IP) with anti–PLC-g1,
resolved by 10% SDS-PAGE, transferred to polyvinylidene difluoride
membranes, and blotted with antiphosphotyrosine (p-tyr). The blot was
subsequently stripped and reprobed with PLC-g1 antibody. Numbers in-
dicate relative band intensity of the antiphosphotyrosine blot as deter-
mined by densitometric scanning and averaging to the relative intensity of
bands obtained by PLC-g1 reblotting.1433 Sommers et al.
with antibody specific for Va11) was decreased in txk  3
AND mice relative to non-txk transgenic AND litter-
mates (Fig. 6, c and d). As with the H-Y transgenics, total
thymocyte numbers were similar between AND and txk 3
AND mice, and the number of transgenic TCRhi (Va11hi)
DP thymocytes was increased in txk 3 AND relative to
AND mice (Fig. 6, c and d). The decrease in SP transgenic
TCRhi thymocytes in txk 3 H-Y and txk 3 AND mice
suggests that either fewer DP transgenic TCRhi thymocytes
are positively selected in these mice, or that the transgenic
TCRhi SP thymocytes normally generated by positive se-
lection are undergoing negative selection.
Overexpression of Txk Can Partially Rescue the Developmental
Defect in itk2/2 Mice. Since Txk and Itk are related kinases
that appear to have similar functions in the calcium signal-
ing pathway, we also examined whether Txk could substi-
tute for Itk. The efficiency of positive selection is markedly
reduced in itk2/2 mice as measured in both H-Y TCR
Figure 6. Positive selection in Txk
transgenic mice. (a) Positive selection
in txk transgenic (tg) 3 H-Y TCR
transgenic female mice. Thymocytes
from representative H-Y female and
H-Y 3 txk transgenic littermate fe-
male mice were stained with anti-
CD4, anti-CD8, and T3.70 (which
stains the H-Y transgenic TCR) anti-
bodies and analyzed by flow cytome-
try. CD4 vs. CD8 profiles of total (top
panel) and T3.70hi (gated) thymocytes
(bottom panel) are shown. Percent-
ages of thymocytes are shown within
the dot plots. Single color histograms
of T3.70 staining are also shown to
indicate placement of the gates. (b)
Thymocyte numbers in H-Y female
and H-Y 3 Txk transgenic littermate
female mice. Numbers of total thy-
mocytes, DP thymocytes, and CD8
SP thymocytes (gated as T3.70hi) for
n  5  11 mice are shown. Identical
symbols indicate individual experi-
ments in which age-matched mice
were chosen. (c) Positive selection in
txk  3 AND TCR littermate trans-
genic mice. Thymocytes from repre-
sentative AND and txk  3 AND
transgenic mice were stained with
anti-CD4, anti-CD8, and anti-Va11
(which recognizes the TCR-a chain
of the AND transgenic TCR) anti-
bodies and analyzed by flow cytome-
try. CD4 vs. CD8 profiles of total (top
panel) and Va11hi (gated) thymocytes
(bottom panel) are shown. Single
color histograms of Va11 staining are
also shown to indicate placement of
the gates. (d) Thymocyte numbers in
AND and txk 3 AND littermate
transgenic mice. Numbers of total
thymocytes, DP, and CD4 SP thy-
mocytes (gated as Va11hi) for n 5 6
mice. Identical symbols indicate indi-
vidual experiments in which age-
matched mice were chosen.
Table II. Dosage Effect of Txk Transgene in H-Y TCR 
Transgenic Female Mice
No. DP
T3.70high
thymocytes
No. CD8 SP
T3.70high
thymocytes
3106 3106
Experiment 1 txk tg 7.56 4.71
txk tg/tg 8.58 2.20
Experiment 2 txk tg 4.69 5.53
txk tg/tg 6.04 3.83
Thymocytes from littermate H-Y 3 txk hemizygous transgenic female
mice (txk tg) and H-Y 3 txk homozygous female mice (txk tg/tg) were
stained with anti-CD4, anti-CD8, and T3.70 antibodies and analyzed
by flow cytometry. Numbers of T3.70high DP and T3.70high CD8 SP
thymocytes were determined.1434 Effects of Txk Overexpression on T Cell Activation
transgenic and AND TCR transgenic mice (21; and Fig. 7).
Significantly, introduction of the txk transgene into the
itk2/2 background partially restored the generation of
transgenic TCRhi SP thymocytes (Fig. 6) and peripheral T
cells (data not shown) in both H-Y TCR and AND TCR
transgenic mice. Moreover, the unusual transgenic TCRhi
population of DN thymocytes, which is expanded in itk2/2
TCR transgenic mice (21), was reduced to levels compara-
ble to those seen in itk1/2 or itk1/1 mice upon expression
of the txk transgene (Fig. 7). In addition, both the TCR-
induced calcium response (Fig. 8 a) and TCR-induced
PLC-g1 tyrosine phosphorylation (Fig. 8 b) were normal-
ized in itk2/2 txk transgenic mice. These results demonstrate
that, in spite of the structural differences between Txk and
Itk, overexpression of Txk can at least partially reverse the
developmental and signal transduction defects in itk2/2 mice.
Discussion
By overexpressing the Tec family kinase Txk in trans-
genic mice, we observed specific effects on TCR signaling,
which include selective augmentation of the calcium sig-
naling pathway, enhanced cytokine production, and alter-
ations in positive selection. These effects were not due to a
chance integration effect of the transgene, since a second
founder line with lower Txk expression had similar but re-
duced effects (data not shown).
Engagement of the TCR results in the activation of at
least two major intracellular signaling pathways (for a re-
view, see reference 34). One pathway leads to the activa-
tion of Ras and MAP kinases, the other to the initiation of
phosphoinositol lipid metabolism. Activation of phosphati-
dylinositol 39-hydroxyl kinase results in the generation of
phosphatidylinositol 3,4-bisphosphate in addition to other
Figure 7. Txk reconstitution of itk2/2
mice. Positive selection was assessed in
TCR transgenic itk1/2 or itk2/2 thymocytes
in the presence or absence of the txk trans-
gene. Thymocytes from H-Y TCR trans-
genic female and AND TCR transgenic
mice were stained with anti-CD4, anti-
CD8, and T3.70 (which stains the H-Y
transgenic TCR) or anti-Va11 (which
stains the AND transgenic TCR) and ana-
lyzed by flow cytometry. CD4 vs. CD8
profiles of total (top panels in each set) or
T3.70hi (gated) or Va11hi (gated) thy-
mocytes (bottom panels in each set) are
shown. Percentages of thymocytes are
shown within the dot plots. Histograms of
T3.70 and Va11 staining on total thy-
mocytes are shown below the dot plots to
indicate placement of the gates. Numbers
above the plots indicate the total number of
thymocytes. The results shown are repre-
sentative of at least three experiments.
Figure 7. Txk reconstitution of itk2/2
mice. Positive selection was assessed in
TCR transgenic itk1/2 or itk2/2 thymocytes
in the presence or absence of the txk trans-
gene. Thymocytes from H-Y TCR trans-
genic female and AND TCR transgenic
mice were stained with anti-CD4, anti-
CD8, and T3.70 (which stains the H-Y
transgenic TCR) or anti-Va11 (which
stains the AND transgenic TCR) and ana-
lyzed by flow cytometry. CD4 vs. CD8
profiles of total (top panels in each set) or
T3.70hi (gated) or Va11hi (gated) thy-
mocytes (bottom panels in each set) are
shown. Percentages of thymocytes are
shown within the dot plots. Histograms of
T3.70 and Va11 staining on total thy-
mocytes are shown below the dot plots to
indicate placement of the gates. Numbers
above the plots indicate the total number of
thymocytes. The results shown are repre-
sentative of at least three experiments.1435 Sommers et al.
phosphoinositol lipids. The products of phosphatidylinositol
3,4-bisphosphate breakdown by PLC-g stimulate calcium
release from intracellular stores (36) and activate the protein
kinase C pathway (34). Several Tec family members have
been implicated in phosphoinositol lipid metabolism path-
ways. Phosphatidylinositol 39-hydroxyl kinase has been shown
to activate the kinase activities of both Btk and Itk (37, 38)
probably through the generation of inositol phosphates,
which can bind the PH domains of Btk and Itk, targeting
them to the cell membrane (39–41). Btk and Itk are then
phosphorylated by Src superfamily kinases, resulting in
their activation (37, 38, 42–46). Since Txk lacks a PH do-
main, either another mechanism mediates its cell membrane
localization or this step is not essential for its activation.
Btk action is thought to be mediated, at least in part, by
the downstream activation of PLC-g2, the major PLC-g
isoform expressed in B cells (25, 26). In cells mutant for
Btk, PLC-g2 phosphorylation was reduced, leading to a
defect in B cell receptor–mediated phosphoinositol hydro-
lysis and calcium influx. In T cells, absence of Itk results in
decreased phosphorylation of PLC-g1 and decreased calcium
flux in response to TCR stimulation (27). Txk appears to
function similarly to Itk in T cells as evidenced by the fur-
ther impairment in PLC-g1–mediated signaling responses in
mice made deficient for both itk and txk (24), and by the in-
crease in tyrosine phosphorylation of PLC-g1 and in intracel-
lular calcium responses observed here in txk transgenic thymo-
cytes. Moreover, Itk and Txk function specifically within
the calcium signaling pathway, as TCR proximal signaling
events such as phosphorylation of TCR-z and ZAP-70 are
unaffected in itk2/2 (27), itk2/2 3 txk2/2 (24), and txk trans-
genic mice (Fig. 4). Activation of Vav and Erk-2 is also un-
affected in txk transgenic mice; however, decreased MAP
kinase activation was noted in itk2/2 3 txk2/2 mice (24).
Although Txk and Itk appear to perform similar functions
in terms of enhancing PLC-g1 phosphorylation and the
calcium response to TCR cross-linking, endogenous Txk
cannot replace Itk, since significant defects in PLC-g1
phosphorylation and calcium flux are readily observed in
itk2/2 mice (27). However, we have shown that overexpres-
sion of Txk can, at least partially, restore the defect in thy-
mocyte selection (Fig. 7) and calcium mobilization (Fig. 8
a) in itk2/2 mice. One explanation for these results could
be that Txk and Itk are functionally redundant but that en-
dogenous Itk is expressed at significantly higher levels than
endogenous Txk, such that Txk overexpression is required
to correct the itk2/2 defect. Alternatively, Txk may func-
tion inefficiently as a substitute for Itk, perhaps due to its
lack of a PH domain. A similar example of partially redun-
dant Src family tyrosine kinases in T cells was observed when
expression of a constitutively active Fyn transgene in lck2/2
mice resulted in partial rescue of thymocyte development
(47). It is also important to note that our results do not ex-
clude the possibility that Txk indirectly enhances PLC-g1
phosphorylation through some as yet unknown intermediary.
We also addressed whether overexpression of Txk could
correct the defect in positive selection in itk2/2 mice. In
the absence of Itk, positive selection of thymocytes bearing
a defined transgenic TCR (H-Y or AND) is severely re-
duced (21). Overexpression of Txk in itk2/2 mice partially
reversed this defect, suggesting that Txk could substitute
for Itk. An additional observation made by Liao and Litt-
man (21) and borne out here is the presence of an increased
number of transgenic TCRhi DN thymocytes in H-Y and
AND transgenic itk2/2 mice. Although the identity of these
cells is unknown, their number decreased with Txk over-
expression, suggesting a return toward a normal phenotype
and a redundancy in function between Txk and Itk. There-
fore, these experiments reveal a similar role for Txk and Itk
in the signaling pathway required for positive selection.
Txk overexpression also influenced the efficiency of pos-
itive selection in the wild-type (itk1/1) background. This
effect was seen only in TCR transgenic mice and therefore
did not represent a generalized inhibition of positive selec-
tion, but rather seems to be due to the alteration in the sig-
naling response of the TCR. In contrast to the rescuing ef-
fect of Txk overexpression in itk2/2 mice, in wild-type
(itk1/1) mice Txk overexpression resulted in the generation
of fewer transgenic TCRhi SP thymocytes in both H-Y
TCR transgenic and AND TCR transgenic mice. If Txk
Figure 8. (a) The calcium response is en-
hanced in itk2/2 txk  transgenic thymocytes.
Thymocytes from itk2/2 and itk2/2 txk trans-
genic mice were preloaded with the calcium
dye indo-1 and then stimulated by the addi-
tion of 5.0 mg of biotin-H57 (anti–TCR-b)
antibody at 30 s and 20 mg of streptavidin
(cross-linking agent) at 60 s. Fluorescence in-
dicating bound and unbound indo-1 was
monitored over time (5 min), and kinetic data
were analyzed using WinList software. The
cells were also stained with anti-CD4 and
anti-CD8, so that calcium flux data could
be obtained on gated DP thymocytes. Ratio
fluorescence (violet/blue, y axis) is plotted
against time (x axis). (b) Time course of
PLC-g1 phosphorylation after TCR cross-linking. Thymocytes from itk2/2 or itk2/2 txk hemizygous transgenic (itk2/2, txk tg) mice were isolated and enu-
merated. Thymocytes (108) were then incubated with biotinylated anti-TCR (H57) and anti-CD4 (GK1.5) on ice and cross-linked with streptavidin at 378C
for the times indicated. Cell lysates were immunoprecipitated with anti–PLC-g1, resolved by 10% SDS-PAGE, transferred to polyvinylidene difluoride mem-
branes, and blotted with antiphosphotyrosine (p-tyr). The blot was subsequently stripped and reprobed with PLC-g1 antibody to assess loading consistency.1436 Effects of Txk Overexpression on T Cell Activation
overexpression enhances TCR signaling as suggested by
our biochemical and functional analysis, it might have been
predicted that the efficiency of positive selection would in-
crease in TCR transgenic mice, resulting in the generation
of more rather than fewer transgenic TCRhi SP thymocytes.
Other genetic alterations that enhance TCR signaling have
been shown to increase the efficiency of positive selection
in TCR transgenic mice as assessed by criteria similar to
those employed here. For example, in the absence of CD5,
which exerts an inhibitory effect on TCR signaling, thy-
mocytes are hyperresponsive to TCR cross-linking, and
the efficiency of positive selection is enhanced in H-Y
TCR transgenic mice (48). Similar effects on positive se-
lection were observed in CD451/2 mice as assessed in P14
TCR transgenic mice (49). However, negative selection
was also enhanced in CD451/2 mice as assessed by lympho-
cytic choriomeningitis virus infection (49). In our experi-
ments, we observed fewer transgenic TCRhi SP thymo-
cytes in txk transgenic mice. This result could be explained
by the failure of txk transgenic thymocytes to signal appro-
priately for positive selection, perhaps due to the delivery
of an unbalanced TCR signal resulting from selective aug-
mentation of the PLC-g/calcium pathway relative to other
downstream pathways such as the Ras pathway. Alterna-
tively, the reduction in transgenic TCRhi SP thymocytes in
txk transgenic mice could be attributed to induction of cell
death (negative selection) as a result of increased TCR sig-
naling. In fact, negative selection has been shown to be
particularly sensitive to alterations in calcium flux (50, 51).
Elevated calcium responses have been correlated with neg-
ative selection in H-Y transgenic mice (50) and in TCR
transgenic fetal thymic organ cultures treated with altered
peptide ligands (52). In addition, in B cells, qualitatively dif-
ferent calcium signals can result in differential transcrip-
tional responses (53, 54), suggesting that the kinetics of the
calcium response can selectively influence the expression of
specific genes.
Although negative selection was unaffected by Txk over-
expression in H-Y transgenic male mice (data not shown),
increased cell death may still account for the apparent de-
crease in positive selection seen in H-Y female and AND
transgenic mice. Negative selection occurs early in H-Y
male thymocytes, before the DP stage (55), and enhance-
ment of negative selection has been difficult to demonstrate
using this particular system. Since we observed normal thy-
mocyte cellularity and increased numbers of transgenic
TCRhi DP thymocytes in txk transgenic 3 TCR transgenic
mice, enhanced cell death may be occurring at a later stage
(e.g., the early SP stage [56]). Consistent with this idea, a
higher percentage of thymocytes from txk transgenic mice
undergoes apoptosis when cultured either in the absence or
presence of stimulating antibodies (anti-TCR plus anti-
CD28) compared with thymocytes from non-txk transgenic
mice (data not shown). Although these findings are subject
to other interpretations, we favor the hypothesis that in-
creased apoptosis of txk transgenic thymocytes cultured in
the absence of stimulating antibodies reflects the outcome of
signals generated in vivo. Indeed, PLC-g1 was found to be
hyperphosphorylated in ex vivo thymocytes from txk trans-
genic mice, indicating enhanced signaling in vivo.
In conclusion, our results identify a specific role for Txk
in the TCR signaling pathway leading to calcium mobili-
zation, and demonstrate that Txk can influence the effi-
ciency of positive selection. In addition, these findings re-
veal a similarity in function for the Tec family kinases Txk
and Itk in T cells.
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